Midecamycin
CAS No. 35457-80-8
Midecamycin ( Antibiotic SF-837;Espinomycin A;Medecamycin A1;Platenomycin B1;Rubimycin;Turimycin P3 )
Catalog No. M19882 CAS No. 35457-80-8
Midecamycin an acetoxy-substituted macrolide antibiotic has effective on gram-positive and gram-negative bacteria acts by inhibiting bacterial protein synthesis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
25MG | 35 | In Stock |
|
50MG | 50 | In Stock |
|
100MG | 71 | In Stock |
|
200MG | Get Quote | In Stock |
|
500MG | Get Quote | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMidecamycin
-
NoteResearch use only not for human use.
-
Brief DescriptionMidecamycin an acetoxy-substituted macrolide antibiotic has effective on gram-positive and gram-negative bacteria acts by inhibiting bacterial protein synthesis.
-
DescriptionMidecamycin an acetoxy-substituted macrolide antibiotic has effective on gram-positive and gram-negative bacteria acts by inhibiting bacterial protein synthesis.
-
SynonymsAntibiotic SF-837;Espinomycin A;Medecamycin A1;Platenomycin B1;Rubimycin;Turimycin P3
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
RecptorAntibacterial
-
Research AreaInflammation/Immunology
-
Indicationinfections in the oral cavity upper and lower respiratory tracts and skin and soft tissue infections.
Chemical Information
-
CAS Number35457-80-8
-
Formula Weight813.97
-
Molecular FormulaC41H67NO15
-
Purity>98% (HPLC)
-
SolubilityDMSO: 50 mg/mL;Ethanol: 50 mg/mL;Water: Insoluble
-
SMILESCCC(=O)O[C@H]1[C@H](C)O[C@H](C[C@@]1(C)O)O[C@@H]1[C@@H](C)O[C@@H](O[C@H]2[C@@H](CC=O)C[C@@H](C)[C@@H](O)\C=C\C=C\C[C@@H](C)OC(=O)C[C@@H](OC(=O)CC)[C@@H]2OC)[C@H](O)[C@H]1N(C)C
-
Chemical Name7-(Formylmethyl)-410-dihydroxy-5-methoxy-916-dimethyl-2-oxooxacyclohexadeca-1113-dien-6-yl 36-dideoxy-4-O-(26-dideoxy-3-C-methyl-alpha-L-ribo-hexopyranosyl)-3-(dimethylamino)-beta-D-glucopyranoside 4'4''-dipropionate (ester)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Neu HC. In vitro activity of midecamycin a new macrolide antibiotic. Antimicrob Agents Chemother. 1983 Sep;24(3):443-4.
molnova catalog
related products
-
Iclaprim
Iclaprim is a novel specific bacterial Dihydrofolate inhibitor.
-
Contezolid
Contezolid (MRX I) is an orally active oxazolidinone agent with antibacterial activity Gram-positive pathogens, including MRSA, penicillin-PRSP, PISP, and vancomycin-resistant enterococci (VRE) with MIC of 0.25-4 ug/mL.
-
Norlichexanthone
Norlichexanthone has the potential to treat and/or prevent lifestyle-related diseases such as type 2 diabetes, metabolic syndrome, atherosclerosis and cardiovascular disease.